Key Points
- SVP Shriram Revankar sold 3,000 shares on Nov. 21 at an average price of $65.55 for $196,650, trimming his position by 4.26% to 67,435 shares (about $4.42M).
- Dolby beat quarterly expectations, reporting $0.99 EPS versus $0.70 expected and $307.02M revenue, and provided FY2026 guidance of $4.190–4.340 EPS (Q1 guidance 0.790–0.940).
- The company raised its quarterly dividend to $0.36 ($1.44 annualized, ~2.2% yield); the ex-dividend date is Dec. 2 and the payment date is Dec. 10.
Dolby Laboratories (NYSE:DLB - Get Free Report) SVP Shriram Revankar sold 3,000 shares of the firm's stock in a transaction that occurred on Friday, November 21st. The shares were sold at an average price of $65.55, for a total transaction of $196,650.00. Following the completion of the sale, the senior vice president owned 67,435 shares in the company, valued at $4,420,364.25. The trade was a 4.26% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink.
Dolby Laboratories Trading Down 1.2%
Shares of NYSE DLB opened at $66.69 on Tuesday. The stock has a 50 day simple moving average of $68.49 and a 200-day simple moving average of $72.28. The company has a market cap of $6.39 billion, a PE ratio of 24.43 and a beta of 0.97. Dolby Laboratories has a 12-month low of $64.02 and a 12-month high of $89.66.
Dolby Laboratories (NYSE:DLB - Get Free Report) last posted its earnings results on Tuesday, November 18th. The electronics maker reported $0.99 EPS for the quarter, beating the consensus estimate of $0.70 by $0.29. The firm had revenue of $307.02 million for the quarter, compared to analysts' expectations of $305.76 million. Dolby Laboratories had a return on equity of 11.52% and a net margin of 19.62%.The firm's revenue was up .7% compared to the same quarter last year. During the same period last year, the firm earned $0.61 EPS. Dolby Laboratories has set its FY 2026 guidance at 4.190-4.340 EPS. Q1 2026 guidance at 0.790-0.940 EPS. Sell-side analysts forecast that Dolby Laboratories will post 2.94 earnings per share for the current fiscal year.
Dolby Laboratories Increases Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 10th. Investors of record on Tuesday, December 2nd will be paid a dividend of $0.36 per share. This is an increase from Dolby Laboratories's previous quarterly dividend of $0.33. This represents a $1.44 dividend on an annualized basis and a dividend yield of 2.2%. The ex-dividend date is Tuesday, December 2nd. Dolby Laboratories's dividend payout ratio (DPR) is presently 54.75%.
Institutional Trading of Dolby Laboratories
A number of large investors have recently added to or reduced their stakes in DLB. Norges Bank bought a new position in shares of Dolby Laboratories in the second quarter valued at $55,030,000. AQR Capital Management LLC grew its holdings in shares of Dolby Laboratories by 51.8% in the 2nd quarter. AQR Capital Management LLC now owns 1,736,260 shares of the electronics maker's stock worth $128,935,000 after acquiring an additional 592,282 shares during the last quarter. Vanguard Group Inc. raised its position in shares of Dolby Laboratories by 7.1% during the first quarter. Vanguard Group Inc. now owns 7,535,722 shares of the electronics maker's stock worth $605,194,000 after purchasing an additional 502,110 shares during the period. Jones Financial Companies Lllp lifted its holdings in shares of Dolby Laboratories by 241,160.1% during the first quarter. Jones Financial Companies Lllp now owns 429,443 shares of the electronics maker's stock valued at $36,975,000 after purchasing an additional 429,265 shares during the last quarter. Finally, First Trust Advisors LP boosted its position in shares of Dolby Laboratories by 35.2% in the 2nd quarter. First Trust Advisors LP now owns 1,237,443 shares of the electronics maker's stock valued at $91,893,000 after purchasing an additional 322,063 shares during the period. 58.56% of the stock is currently owned by institutional investors.
Wall Street Analyst Weigh In
A number of equities analysts recently issued reports on DLB shares. Tigress Financial increased their target price on shares of Dolby Laboratories from $112.00 to $114.00 and gave the company a "buy" rating in a research report on Friday, August 15th. Baird R W upgraded shares of Dolby Laboratories to a "hold" rating in a report on Friday, September 5th. Barrington Research dropped their target price on Dolby Laboratories from $100.00 to $95.00 and set an "outperform" rating on the stock in a report on Wednesday, November 19th. Robert W. Baird initiated coverage on Dolby Laboratories in a research report on Friday, September 5th. They issued a "neutral" rating and a $74.00 target price for the company. Finally, Wall Street Zen cut Dolby Laboratories from a "buy" rating to a "hold" rating in a research report on Saturday. Three analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company's stock. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average price target of $92.00.
Read Our Latest Analysis on Dolby Laboratories
Dolby Laboratories Company Profile
(
Get Free Report)
Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
